Kashi Clinical Laboratories Announces Partnership With Prairie Capital

On June 20, 2024, founder Dr. Zahra Kashi and senior management partnered with Prairie Capital to recapitalize Kashi Clinical Laboratories. Headquartered in Portland, OR, Kashi Clinical Laboratories is a fully accredited clinical laboratory providing specialized solutions to academic institutions, biopharma, hospitals, long-term care facilities, and transplant centers around the world.

The company was founded in 2006 to provide high-resolution HLA typing for transplant donor matching. Over time, Kashi expanded its service offerings to include post-transplant monitoring, genomic sequencing, and other diagnostic testing. Kashi enjoys industry-leading customer satisfaction and is renowned for its rapid turnaround time, scientific expertise, customer service, and innovation using state-of-the-art technology.

Kashi Clinical Laboratories partnered with Prairie to accelerate growth through strategic investments in human capital, sales and marketing, technology, infrastructure, new services, and add-on acquisitions.